Functionalizing Ferritin Nanoparticles for Vaccine Development

In the last decade, the interest in ferritin-based vaccines has been increasing due to their safety and immunogenicity. Candidates against a wide range of pathogens are now on Phase I clinical trials namely for influenza, Epstein-Barr, and SARS-CoV-2 viruses. Manufacturing challenges related to part...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues, Margarida Q., Alves, Paula M., Roldão, António
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540537/
https://www.ncbi.nlm.nih.gov/pubmed/34683914
http://dx.doi.org/10.3390/pharmaceutics13101621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540537/
https://www.ncbi.nlm.nih.gov/pubmed/34683914
http://dx.doi.org/10.3390/pharmaceutics13101621

Ejemplares similares